Matti Maimets

2.9k total citations
21 papers, 256 citations indexed

About

Matti Maimets is a scholar working on Cellular and Molecular Neuroscience, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Matti Maimets has authored 21 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Infectious Diseases and 5 papers in Molecular Medicine. Recurrent topics in Matti Maimets's work include Antibiotic Resistance in Bacteria (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and HIV Research and Treatment (3 papers). Matti Maimets is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and HIV Research and Treatment (3 papers). Matti Maimets collaborates with scholars based in Estonia, Norway and United Kingdom. Matti Maimets's co-authors include Piret Mitt, Katrin Lang, Paul Naaber, Kaidi Telling, Siiri Kõljalg, Irja Lutsar, Tuuli Metsvaht, Eda Tamm, Age Brauer and Veljo Kisand and has published in prestigious journals such as Clinical Microbiology and Infection, Pharmacology Biochemistry and Behavior and Infection Control and Hospital Epidemiology.

In The Last Decade

Matti Maimets

20 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matti Maimets Estonia 9 71 69 49 46 40 21 256
Yvonne Hendriks Netherlands 8 123 1.7× 61 0.9× 96 2.0× 69 1.5× 16 0.4× 11 303
Biljana Carević Serbia 9 72 1.0× 63 0.9× 78 1.6× 78 1.7× 16 0.4× 13 247
Prithwis Bhattacharyya India 10 61 0.9× 33 0.5× 71 1.4× 37 0.8× 50 1.3× 38 346
Till Dresbach Germany 8 41 0.6× 56 0.8× 36 0.7× 44 1.0× 45 1.1× 33 236
Egidia Miftode Romania 11 64 0.9× 123 1.8× 48 1.0× 171 3.7× 22 0.6× 61 350
Hiroshi Morioka Japan 9 86 1.2× 71 1.0× 45 0.9× 57 1.2× 12 0.3× 40 278
Yohann Dubois France 5 35 0.5× 155 2.2× 59 1.2× 41 0.9× 39 1.0× 7 339
Frederick J. Buckwold Canada 9 100 1.4× 137 2.0× 54 1.1× 52 1.1× 29 0.7× 10 358
M. Paul Israel 8 33 0.5× 142 2.1× 96 2.0× 67 1.5× 19 0.5× 10 362
D. Bogaers‐Hofman Netherlands 4 151 2.1× 77 1.1× 26 0.5× 198 4.3× 48 1.2× 5 340

Countries citing papers authored by Matti Maimets

Since Specialization
Citations

This map shows the geographic impact of Matti Maimets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Maimets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Maimets more than expected).

Fields of papers citing papers by Matti Maimets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Maimets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Maimets. The network helps show where Matti Maimets may publish in the future.

Co-authorship network of co-authors of Matti Maimets

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Maimets. A scholar is included among the top collaborators of Matti Maimets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Maimets. Matti Maimets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Telling, Kaidi, Age Brauer, Mailis Laht, et al.. (2020). Characteristics of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae and Contact to Animals in Estonia. Microorganisms. 8(8). 1130–1130. 6 indexed citations
2.
Telling, Kaidi, Mailis Laht, Age Brauer, et al.. (2018). Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals. BMC Infectious Diseases. 18(1). 513–513. 26 indexed citations
3.
Simmons, Ruth, Kristi Huik, Matti Maimets, et al.. (2017). HIV incidence in the Estonian population in 2013 determined using the HIV‐1 limiting antigen avidity assay. HIV Medicine. 19(1). 33–41. 14 indexed citations
4.
Avi, Radko, et al.. (2015). Design and structure of the Estonian HIV Cohort Study (E-HIV). Infectious Diseases. 47(11). 768–775. 9 indexed citations
5.
Huik, Kristi, et al.. (2014). Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic. BMC Infectious Diseases. 14(S4). 1 indexed citations
6.
Maimets, Matti, et al.. (2014). Lyme’i tõve nüüdisaegne diagnostika ja ravi. Ajakirjad. Journals by UT.
7.
Mitt, Piret, Tuuli Metsvaht, Kaidi Telling, et al.. (2013). Five-year prospective surveillance of nosocomial bloodstream infections in an Estonian paediatric intensive care unit. Journal of Hospital Infection. 86(2). 95–99. 18 indexed citations
8.
Mitt, Piret, Heti Pisarev, Tuuli Metsvaht, et al.. (2012). Prolonged outbreak of Serratia marcescens in Tartu University Hospital: a case–control study. BMC Infectious Diseases. 12(1). 281–281. 20 indexed citations
9.
Mitt, Piret, et al.. (2009). Epidemiology of nosocomial bloodstream infections in Estonia. Journal of Hospital Infection. 71(4). 365–370. 32 indexed citations
10.
Tamm, Eda, Paul Naaber, Matti Maimets, et al.. (2007). Antimicrobial susceptibility and serogroup/serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae in healthy Estonian children in 1999–2003. Clinical Microbiology and Infection. 13(8). 824–826. 7 indexed citations
11.
Mitt, Piret, et al.. (2005). Surgical-Site Infections Following Cesarean Section in an Estonian University Hospital: Postdischarge Surveillance and analysis of Risk Factors. Infection Control and Hospital Epidemiology. 26(5). 449–454. 76 indexed citations
12.
Tamm, Eda, et al.. (2000). Nasopharyngeal carriage and antibacterial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Estonian children. Clinical Microbiology and Infection. 6(12). 675–677. 13 indexed citations
13.
Naaber, Paul, Siiri Kõljalg, & Matti Maimets. (2000). Antibiotic usage and resistance — trends in Estonian University Hospitals. International Journal of Antimicrobial Agents. 16(3). 309–315. 19 indexed citations
14.
Vasar, Eero, Matti Maimets, & Lembit Allikmets. (1986). Role of the serotonin2-receptors in regulation of aggressive behavior. Neuroscience and Behavioral Physiology. 16(2). 118–124. 4 indexed citations
15.
Vasar, Eero, et al.. (1986). Comparison of motor depressant effects of caerulein and N-propylnorapomorphine in mice. Pharmacology Biochemistry and Behavior. 24(3). 469–478. 2 indexed citations
16.
Maimets, Matti, et al.. (1986). Different effects of long-term haloperidol administration on GABAA and benzodiazepine receptors in various parts of the brain. Bulletin of Experimental Biology and Medicine. 101(4). 460–463. 2 indexed citations
17.
Vasar, Eero, et al.. (1985). Modulating effect of cerulein on benzodiazepine receptors. Bulletin of Experimental Biology and Medicine. 100(6). 1700–1702. 1 indexed citations
18.
Vasar, Eero, et al.. (1985). Stimulation of [3H]spiroperidol binding after prolonged neuroleptic therapy by the cholecystokinin octapeptide analog cerulein. Bulletin of Experimental Biology and Medicine. 99(1). 87–89. 2 indexed citations
19.
Vasar, Eero, et al.. (1984). Caerulein stimulates [3H]-spiperone binding in vivo after long-term haloperidol administration.. PubMed. 20(4). 691–2. 2 indexed citations
20.
Vasar, Eero, Matti Maimets, & Lembit Allikmets. (1984). [Role of serotonin2 receptors in regulating aggressive behavior].. PubMed. 34(2). 283–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yvonne Hendriks Breakdown of academic impact, for papers by Biljana Carević Breakdown of academic impact, for papers by Prithwis Bhattacharyya Breakdown of academic impact, for papers by Till Dresbach Breakdown of academic impact, for papers by Egidia Miftode Breakdown of academic impact, for papers by Hiroshi Morioka Breakdown of academic impact, for papers by Yohann Dubois Breakdown of academic impact, for papers by Frederick J. Buckwold Breakdown of academic impact, for papers by M. Paul Breakdown of academic impact, for papers by D. Bogaers‐Hofman
Rankless by CCL
2026